OSTEOMEAL Trademark

Trademark Overview

On Tuesday, October 24, 2006, a trademark application was filed for OSTEOMEAL with the United States Patent and Trademark Office. The USPTO has given the OSTEOMEAL trademark a serial number of 77027994. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 16, 2018. This trademark is owned by Liptis Laboratories, Inc.. The OSTEOMEAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of calcium deficiency and osteoporosis
osteomeal

General Information

Serial Number77027994
Word MarkOSTEOMEAL
Filing DateTuesday, October 24, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 16, 2018
Registration Number3412156
Registration DateTuesday, April 15, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of calcium deficiency and osteoporosis
Pseudo MarkOSTEO MEAL

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 16, 2018
Primary Code005
First Use Anywhere DateSaturday, December 15, 2007
First Use In Commerce DateFriday, February 1, 2008

Trademark Owner History

Party NameLIPTIS PHARMACEUTICALS USA, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSpring Valley, NY 10977
Party NameLiptis Laboratories, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBronx, NY 10472
Party NameLiptis Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBronx, NY 10472
Party NameLiptis Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBronx, NY 10472

Trademark Events

Event DateEvent Description
Friday, November 16, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, April 15, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, October 21, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 31, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, October 31, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 16, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, October 30, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 16, 2013TEAS SECTION 8 & 15 RECEIVED
Thursday, July 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 3, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 15, 2008REGISTERED-PRINCIPAL REGISTER
Friday, March 7, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, March 5, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 5, 2008STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 7, 2008USE AMENDMENT FILED
Thursday, February 7, 2008TEAS STATEMENT OF USE RECEIVED
Tuesday, August 21, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 29, 2007PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2007NOTICE OF PUBLICATION
Wednesday, March 28, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 28, 2007ASSIGNED TO LIE
Monday, March 5, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 5, 2007EXAMINER'S AMENDMENT ENTERED
Monday, March 5, 2007EXAMINERS AMENDMENT E-MAILED
Monday, March 5, 2007EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 28, 2007ASSIGNED TO EXAMINER
Saturday, October 28, 2006NOTICE OF PSEUDO MARK MAILED
Friday, October 27, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

osteomeal deficiency osteoporosis calcium treatment preparations pharmaceutical